Showing results (691-700 of 744) with videos related to

Sort By:
Pageof 75
Annals of Neurology|May 1, 2018
Age of first exposure to tackle football and chronic traumatic encephalopathyMichael L Alosco, Jesse Mez, Yorghos Tripodis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 3, 2025
Identification of GGC Repeat Expansions in ZFHX3 among Chilean Movement Disorder PatientsPaula Saffie-Awad, Abraham Moller, Kensuke Daida, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2024
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical TrialAva Y Xu, Gustavo E Velásquez, Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Defining a tandem repeat catalog and variation clusters for genome-wide analysesBen Weisburd, Egor Dolzhenko, Mark F Bennett, et al.
Translational Psychiatry|September 20, 2017
Age of first exposure to American football and long-term neuropsychiatric and cognitive outcomesM L Alosco, A B Kasimis, J M Stamm, et al.
American Journal of Human Genetics|March 31, 2021
Expectations and blind spots for structural variation detection from long-read assemblies and short-read genome sequencing technologiesXuefang Zhao, Ryan L Collins, Wan-Ping Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2025
Identification of GGC Repeat Expansions in ZFHX3 Among Chilean Movement Disorder PatientsPaula Saffie-Awad, Abraham Moller, Kensuke Daida, et al.
Emerging Infectious Diseases|January 6, 2026
Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020Ekaterina V Kurbatova, William C Whitworth, Kia E Bryant, et al.
Contemporary Clinical Trials|March 10, 2025
Study protocol for a duration-randomized clinical trial to determine the optimal length of treatment for multidrug-resistant tuberculosis with a 5-drug regimen: The DRAMATIC trialPawandeep Kaur, Lelia H Chaisson, Zana Wangari Kiragu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Long-read sequencing identifies FGF14 repeat expansions in Parkinson's diseaseFulya Akçimen, Kensuke Daida, Lara M Lange, et al.
Pageof 75